ArticleGene therapy2009

The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr-/- -dependent allergy mouse model.

C Mueller et al.PubMed ↗Publisher ↗

No numbers read from the abstract.